Shares of Saudi-based Middle East Pharmaceutical Industries Co., known as Avalon Pharma, surged 30% on its trading debut on the Tadawul stock exchange Tuesday after the company raised almost $131.2 million (SAR 492 million) in an IPO earlier this month.
